US Patent Issued to Memorial Sloan Kettering Cancer Center on Sept. 8 for "Anti-GPA33 multi-specific antibodies and uses thereof" (New York Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,246, issued on Sept. 8, was assigned to Memorial Sloan Kettering Cancer Center (New York).

"Anti-GPA33 multi-specific antibodies and uses thereof" was invented by Brian H. Santich (New York), Mao Wang (New York), Nai-Kong V. Cheung (New York), Steven Larson (New York), Sarah Taldone (New York), Darren Veach (New York), Mahiuddin Ahmed (New York) and Hong Xu (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates generally to immunoglobulin-related compositions (e.g., multi-specific antibodies or antigen binding fragments thereof) that can bind to the GPA33 protein. The multi-specific antibodies of the present technolo...